Navigation Links
Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients
Date:10/15/2007

orted, other notable serious adverse events (SAEs) included: prostate cancer, breast cancer, pneumonia, sarcoidosis, abscess and a death following Histoplasmosis pneumonia. (See Important Safety Information below.)

About the PharMetrics Analysis

This retrospective analysis examined medical and pharmacy claims from the PharMetrics Patient Centric database to determine healthcare resource utilization among patients with UC before and after a colectomy. The PharMetrics database contains enrollment data, pharmacy and medial claims from approximately 82 different managed care organizations, consisting of more than 46 million patients in the United States. It is considered representative of the insured population of the United States. Patient data was collected from January 1, 2000 through June 30, 2005, for any patient with a previous diagnosis of UC who had two distinct claims for treatment of UC and had a Current Procedural Terminology (CPT) code indicating colectomy.

A total of 411 patients were included in the analysis, and researchers collected data for each patient both 12 months prior to the colectomy and 12 months following colectomy. The researchers focused on the levels of inpatient, outpatient, emergency room, physician, laboratory and drug costs of care and found that healthcare utilization increased during the 12 months following colectomy. The increases were primarily driven by inpatient and outpatient visits.

The data showed that inpatient encounters increased during the 12 months after colectomy, compared with the number of encounters during the 12 months before colectomy (1.8 vs. 0.9). There were also increases in outpatient visits (19.4 vs. 8.7), emergency room visits (0.9 vs. 0.8), physician visits (14.9 vs. 13.9) and laboratory visits (2.2 vs. 2.1) during the post-colectomy period, compared with the pre-colectomy period.

About Ulcerative Colitis

UC is a chronic inflammatory bowel disease a
'/>"/>

Contact: Melissa Katz
215-325-6875
Centocor, Inc.
Source:Eurekalert

Page: 1 2 3 4 5 6

Related biology news :

1. Roche clinical trial registry and results database launched
2. NIAID begins clinical trial of West Nile virus vaccine
3. Compound might defeat African sleeping sickness, clinical trial beginning this month
4. Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease
5. Dalai Lama, top scientists to discuss science & clinical applications of meditation
6. Stem cells electric abilities might help their safe clinical use
7. Clinical trial to test stem cell approach for children with brain injury
8. New malaria vaccine shows promise in early clinical trial
9. Preclinical study of a new brain tumor therapy
10. Tramiprosate (Alzhemed? preclinical results published in Neurobiology of Aging
11. Fatty spheres loaded with siRNA shrink ovarian cancer tumors in preclinical trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015 ... government policies are boosting access control systems market in ... According to a recently published report by TechSci Research ... ", the access control systems market in ... billion by 2020.The access control systems market in the ...
(Date:4/14/2015)... YORK , April 14, 2015  HYPR ... IDentity Online (FIDO ® ) Alliance tm , ... specifications. FIDO members commit to share technology and ... methods that are interoperable, more secure and private, ... enable biometric identity verification that protects sensitive user ...
(Date:4/10/2015)... , April 10, 2015 Research ... of the "Security Competitive Profiles - NEC" ... , NEC will continue to supply a ... the market, with a company focus on the development ... Winning opportunities in the Asia-Pacific ...
Breaking Biology News(10 mins):Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3NEC Security Competitive Profile 2015 2
... The December issue of The Quarterly Review of ... on the nature of individual organisms, evolution observed in ... criticism of intelligent design creationism. Abstracts are available at ... an Individual? For organisms like fish, mice, ...
... discovered how a network of repair proteins enables bacteria to ... the DNA molecules that carry the instructions necessary for living ... at the University of Bristol and published in Molecular ... between the DNA repair systems of bacteria and humans than ...
... PITTSBURGH Nonchemical treatment systems are touted as environmentally ... it comes to cleaning the water-based air-conditioning systems ... study by University of Pittsburgh researchers suggests that ... ineffective and can allow dangerous bacteria to flourish ...
Cached Biology News:News tips from the Quarterly Review of Biology 2News tips from the Quarterly Review of Biology 3New research reveals details of microbe's extraordinary maintenance and repair system 2Pitt study finds 'green' water treatments may not kill bacteria in large building cooling systems 2
(Date:5/27/2015)... OAKLAND, Calif. , May 27, 2015  Two ... tinkerers, biotech professionals, hackers and citizen scientists, ... a $30,000 crowdfunding campaign promoting its mission to democratize ... city,s Temescal District. ... Based out ...
(Date:5/27/2015)... May 27, 2015 The Medical Innovation ... impact of regulation on medical innovation, has been developed ... of Fairleigh Dickinson University’s ( FDU ) Rothman ... Alert pertains to new FDA (Food & Drug ... accelerating the approval of certain medical devices. , ...
(Date:5/26/2015)... WORMS, GERMANY – May 26, ... GRA) announces that its manufacturing facility in Worms, ... from EXCiPACT™, an independent organization that certifies manufacturers, ... , All three Grace facilities that produce its ... gels have now received GMP certification, following the ...
(Date:5/26/2015)... BioSciences, Inc. (NASDAQ: SGMO ) announced today that ... update on the progress of Sangamo,s ZFP Therapeutic ® ... at 1:30pm ET on Monday, June 1, 2015, at the ... in New York, NY . ... via a link on the Sangamo BioSciences website in the ...
Breaking Biology Technology:East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 2East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 3Medical Innovation Impact Index Launched at Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) under the Rothman Institute 2CORRECTION: Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2Sangamo BioSciences Announces Presentation At The Jefferies 2015 Global Healthcare Conference 2
... SA has announced,today that the first generation ... active against human influenza. Viroblock,s patented,Cholesterol Catalytic ... the extra-cellular phase, by altering and destabilizing,cholesterol-rich ... The two pre-clinical studies exposed ferrets to ...
... County Automates ... Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC ... today announced that its Wyndgate Technologies(R) division has licensed ... Health System of Clinton, South Carolina. Terms of ...
... Claims Cover Phospholipid-Targeting Compounds Linked to Anti-Viral Agents ... March 31 Peregrine Pharmaceuticals, Inc. (Nasdaq: ... a U.S. patent that further strengthens the company,s ... agents for the treatment of life-threatening diseases. ...
Cached Biology Technology:Viroblock SA Reports Positive Results of Preclinical Studies in Antiviral Nasal Spray 2Global Med Technologies(R) Licenses 90th Site in the Southeastern U.S. 2Global Med Technologies(R) Licenses 90th Site in the Southeastern U.S. 3Peregrine Pharmaceuticals Awarded New U.S. Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio 2Peregrine Pharmaceuticals Awarded New U.S. Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio 3Peregrine Pharmaceuticals Awarded New U.S. Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio 4
... SkanIt™ Software is the ultimate ... and data handling. There are two ... Research Edition for scientists working in ... Discovery Edition offering features needed for ...
...
...
Verotoxin IIbeta (457)...
Biology Products: